Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Lithium is the gold-standard treatment for bipolar disorder, a severe mental illness. A large body of evidence suggests that inflammation plays a role in the pathogenesis of bipolar disorder and that mood stabilizers exhibit anti-inflammatory properties. However, contradicting findings have also been reported. In this study, we examined the effects of lithium on LPS-induced inflammation in rat primary glia cells. Cells were pre-treated with lithium (1 or 10 mM) for 6 or 24 h, after which, inflammation was induced by the addition of LPS (for another 18 h) to the culture medium. Thereafter, medium was collected and cells were harvested for further analyses. Levels of TNF-α, IL1-β and PGE 2 were determined by ELISA and NO levels by the Griess reaction assay. Expression levels of cyclooxygenase-2 (COX-2) and inducible NO synthase (iNOS) were examined by Western blot analysis. We found that pre-treatment with lithium 10 mM (but not 1 mM) significantly reduced LPS-induced secretion of TNF-α, IL1-β, PGE 2 and NO. In addition, lithium significantly reduced the expression of COX-2 and iNOS. These findings indicate that lithium exhibits a potent anti-inflammatory effect. However, it’s important to emphasize that this effect was obtained mainly under treatment with an extra-therapeutic concentration of the drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Nitric oxide synthases in mammals
Knowles, R. G., & Moncada, S. (1994) · Biochemical Journal · doi:10.1042/bj2980249 · Cited by 2,752
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321 · cited 1×
“For example, lithium inhibits the multi-functional enzyme glycogen synthase kinase-3 (GSK3).(17,85,86) Inhibition of GSK-3 has been associated with attenuation of inflammatory responses in different experimental models.”
BackgroundGlia — more than just brain glue
Allen, N. J., & Barres, B. A. (2009) · Nature · doi:10.1038/457675a · Cited by 856
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774
Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709 · cited 1×
“2011–8:12am] [1–12] K:/INI/INI 421512.”
Depressive disorders and immunity: 20 years of progress and discovery
Irwin, M. R., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.01.010 · Cited by 676
Gimeno, D., Kivimäki, M., Brunner, E. J., Elovainio, M., De Vogli, R., Steptoe, A., Kumari, M., Lowe, G. D. O., Rumley, A., Marmot, M. G., et al. (2009) · Psychological Medicine · doi:10.1017/s0033291708003723 · Cited by 561
Lithium delays progression of amyotrophic lateral sclerosis
Fornai, F., Longone, P., Cafaro, L., Kastsiuchenka, O., Ferrucci, M., Manca, M. L., Lazzeri, G., Spalloni, A., Bellio, N., Lenzi, P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708022105 · Cited by 550 · cited 1×
“The use of lithium is expected to further increase in coming years as it has recently been suggested as a treatment for other illnesses, including schizoaffective disorder,(8) neurodegenerative diseases, such as Alzheimer’s disease and amyotrophic lateral sclerosis.(12) Nevertheless, lithium therapy is complicated by…”
BackgroundMaes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.014 · Cited by 544
Belmaker, R. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035354 · Cited by 473
Self-citationLicinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380
Padmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336 · cited 3×
“Bipolar disorder has also been associated with altered regulation and synthesis of PGs.(19,21,26,27) The results regarding anti-inflammatory cytokines, such as IL-4 and IL-10 have been less consistent.”
BackgroundNery, F. G., Monkul, E. S., Hatch, J. P., Fonseca, M., Zunta‐Soares, G. B., Frey, B. N., Bowden, C. L., & Soares, J. C. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.912 · Cited by 298
Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.
O'Brien, S. M., Scully, P., Scott, L. V., & Dinan, T. G. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.11.015 · Cited by 285
Chen, P. S., Wang, C.-C., Bortner, C. D., Peng, G.-S., Wu, X., Pang, H., Lu, R.-B., Gean, P.-W., Chuang, D.-M., & Hong, J.-S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.06.053 · Cited by 262
Yuskaitis, C. J., & Jope, R. S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.014 · Cited by 240 · cited 2×
“This confirms previous reports in which lithium reduced LPSinduced inflammation in mouse glia cells.(78,79) Lithium reduced production of the pro-inflammatory mediators NO, TNF-a, IL-1b and PGE2 after stimulation with bacterial endotoxin.”
BackgroundResultDhabhar, F. S., Burke, H. M., Epel, E. S., Mellon, S. H., Rosser, R., Reus, V. I., & Wolkowitz, O. M. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.05.010 · Cited by 225 · cited 1×
“The connection between mood disorders and inflammation is further strengthened by a large body of evidence suggesting that patients with depression have increased levels of pro-inflammatory mediators, while levels of anti-inflammatory cytokines are unchanged,(20,22,23) or either reduced.(41) Similarly, depression is c…”
BackgroundGuo, J.-Y., Li, C.-Y., Ruan, Y.-P., Sun, M., Qi, X.-L., Zhao, B.-S., & Luo, F. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.076 · Cited by 148
Increased plasma levels of 8-iso-PGF2α and IL-6 in an elderly population with depression
Dimopoulos, N., Piperi, C., Psarra, V., Lea, R. W., & Kalofoutis, A. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.07.019 · Cited by 118
Cytokine levels in euthymic bipolar patients
Guloksuz, S., Aktas Cetin, E., Cetin, T., Deniz, G., Oral, E. T., & Nutt, D. J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.027 · Cited by 102 · cited 1×
“However, the increase in TNF-a levels under treatment with 1mM lithium is consistent with previous reports in which therapeutic concentrations of lithium significantly increased plasma TNF-a levels in bipolar patients.(93,94) Furthermore, the mood stabilizer valproate has been shown to reduce the release of TNF-a, int…”
ResultHuang, T.-L., & Lin, F.-C. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.09.010 · Cited by 90
Himmerich, H., Koethe, D., Schuld, A., Yassouridis, A., & Pollm�cher, T. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2038-9 · Cited by 60 · cited 1×
“However, the increase in TNF-a levels under treatment with 1mM lithium is consistent with previous reports in which therapeutic concentrations of lithium significantly increased plasma TNF-a levels in bipolar patients.(93,94) Furthermore, the mood stabilizer valproate has been shown to reduce the release of TNF-a, int…”
Result
Research works printed but not linked: 68
- 10.1111/j.1399-5618.2009.00709.x · DOI · Paper page
- 10.1001/archpsyc.59.2.115 · DOI · Paper page
- 10.4088/JCP.v68n0811 · DOI · Paper page
- 10.1016/j.jpsychires.2007.10.009 · DOI
- Lenox RH, 1998, J Clin Psychiatry, 59, 37
- Goodwin FK, 2002, J Clin Psychiatry, 63, 5
- 10.1016/S0165-0327(02)00354-3 · DOI
- 10.1159/000113715 · DOI
- 10.1038/sj.mp.4001793 · DOI · Paper page
- Bowden CL, 2004, J Clin Psychiatry, 65, 21, 10.4088/JCP.v65n0518 · DOI
- 10.2165/00002018-199920030-00004 · DOI
- 10.1038/341197a0 · DOI · Paper page
- 10.1073/pnas.93.16.8455 · DOI · Paper page
- 10.1016/S0006-3223(99)00165-1 · DOI · Paper page
- 10.1038/mp.2008.31 · DOI
- 10.4088/JCP.08r04505 · DOI · Paper page
- 10.1016/j.brainresrev.2009.06.003 · DOI · Paper page
- 10.1016/j.jneuroim.2004.01.006 · DOI
- 10.1016/j.pnpbp.2007.02.018 · DOI
- 10.2119/2008-00053.Begemann · DOI
- 10.1016/j.neuro.2009.03.004 · DOI
- Kauer-Sant'Anna M, 2008, late-stage bipolar disorder. Int J Neuropsychopharmacol, 12, 447
- 10.1159/000119472 · DOI · Paper page
- 10.1016/j.biopsych.2008.04.023 · DOI
- 10.1016/j.jacc.2007.12.055 · doi:10.1016/j.jacc.2007.12.055
- 10.1016/j.biopsych.2008.11.011 · DOI · Paper page
- 10.1176/appi.ajp.159.6.1029 · DOI · Paper page
- 10.1007/s00406-004-0478-1 · DOI
- 10.1016/S0022-3956(99)00021-7 · DOI · Paper page
- 10.2165/00002512-200017010-00001 · DOI
- 10.1002/ana.20774 · DOI · Paper page
- 10.1038/sj.bjp.0707167 · DOI · Paper page
- 10.1016/j.nbd.2004.03.010 · DOI · Paper page
- 10.1096/fasebj.9.11.7649404 · DOI · Paper page
- 10.1074/jbc.271.52.33157 · DOI · Paper page
- 10.1016/S0165-6147(98)01283-8 · DOI
- 10.2174/1568010043483971 · doi:10.2174/1568010043483971
- 10.1073/pnas.96.1.272 · DOI · Paper page
- 10.1002/(SICI)1097-4547(19970515)48:4<372::AID-JNR9>3.0.CO;2-8 · doi:10.1002/(sici)1097-4547(19970515)48:4<372::aid-jnr9>3.0.co;2-8
- 10.1111/j.1471-4159.2006.03988.x · DOI · Paper page
- 10.1016/j.jad.2007.08.006 · DOI · Paper page
- 10.1080/15622970510029993 · DOI · Paper page
- 10.1038/sj.mp.4001111 · DOI
- 10.1046/j.1471-4159.2001.00311.x · DOI · Paper page
- 10.1016/j.biopsych.2005.07.024 · DOI
- 10.1007/s11064-007-9526-3 · DOI
- 10.1016/S0889-1591(02)00008-9 · DOI
- 10.1002/jnr.21899 · DOI · Paper page
- 10.1074/jbc.M309325200 · DOI
- 10.1074/jbc.M000074200 · DOI · Paper page
- 10.1152/ajprenal.00114.2004 · DOI
- 10.1016/S0378-4274(98)00324-5 · DOI
- 10.1016/0166-2236(96)10049-7 · DOI · Paper page
- 10.1177/09680519000060050801 · DOI
- 10.1177/0968051907080428 · DOI
- 10.1016/0003-2697(82)90118-X · DOI · Paper page
- 10.1016/0003-2697(76)90527-3 · DOI · Paper page
- 10.1186/1742-2094-6-9 · DOI · Paper page
- 10.1038/ni1221 · DOI · Paper page
- 10.1016/S0006-8993(99)02439-7 · DOI · Paper page
- 10.1111/j.1399-5618.2007.00361.x · DOI · Paper page
- 10.1016/j.molbrainres.2004.10.021 · DOI · Paper page
- 10.1016/S0165-6147(03)00206-2 · DOI · Paper page
- 10.1038/35017574 · DOI · Paper page
- 10.1038/sj.bjp.0706509 · DOI · Paper page
- 10.1038/sj.bjp.0706902 · DOI
- 10.1016/j.clim.2006.03.005 · DOI
- 10.1523/JNEUROSCI.13-08-03574.1993 · DOI · Paper page
Cited by
Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402
Forlenza, O. V., De-Paula, V. J. R., & Diniz, B. S. O. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000309 · Cited by 332
Effects of Lithium on Inflammation
Nassar, A., & Azab, A. N. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500038f · Cited by 219
Self-citationBipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers
Muneer, A. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.1.18 · Cited by 187
Hope, S., Ueland, T., Steen, N. E., Dieset, I., Lorentzen, S., Berg, A. O., Agartz, I., Aukrust, P., & Andreassen, O. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2012.12.023 · Cited by 131
Metadata
- Authors
- Nahman, S., Belmaker, R., & Azab, A. N.
- Venue
- Innate Immunity
- Publisher
- SAGE Publications
- Published
- 2011-10-12
- Volume
- 18
- Issue
- 3
- Pages
- 447-458
- ISSN
- 1753-4259 (ISSN-L)
- 1753-4267
- OpenAlex
- W2110194936
- Cited by
- 72
- References
- 26
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.